Accelerating Drug Monetization: PTS Expands in China Market, UnicoCell Completes FDA Registration
NQ Score
0/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Taiwanese biotech companies are accelerating new drug commercialization. PTS partnered with a Chinese firm to promote its lung cancer drug, while UnicoCell completed US FDA DMF registration for its stem cell and exosome ingredients.